buserelin has been researched along with Endometrioma in 176 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 61 (34.66) | 18.7374 |
| 1990's | 96 (54.55) | 18.2507 |
| 2000's | 15 (8.52) | 29.6817 |
| 2010's | 4 (2.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawasaki, S; Sasaki, O; Shinkai, M; Shinoda, M; Sugimura, K | 1 |
| Aso, T; Fukunaga, M; Hagino, H; Harada, T; Momoeda, M; Taketani, Y; Terakawa, N | 1 |
| Akira, S; Kuwabara, Y; Mine, K; Takeshita, T | 1 |
| Akira, S; Ichikawa, M; Iwasaki, N; Kuwabara, Y; Mine, K; Tajima, H; Takeshita, T | 1 |
| Kitawaki, J; Kusuki, I; Suganuma, I; Yamanaka, K | 1 |
| Faustmann, T; Gerlinger, C; Hassall, JJ; Seitz, C | 1 |
| Azuma, Y; Deura, I; Harada, T; Higaki, H; Iwabe, T; Taniguchi, F; Terakawa, N | 1 |
| Fushiki, S; Honjo, H; Ishihara, H; Kado, N; Kitawaki, J; Koshiba, H | 1 |
| Horiguchi, F; Ishitani, K; Makita, K; Nozawa, S; Ohta, H | 1 |
| Harada, T | 1 |
| Fujiwara, M; Harada, N; Kimura, F; Kita, N; Noda, Y; Takahashi, K; Takebayashi, K | 1 |
| Carstensen, A; Mundhenke, C; Schollmeyer, T | 1 |
| Lemay, A; Quesnel, G | 1 |
| Boyle, H; Fraser, HM; Shaw, RW | 1 |
| Fraser, AC; Lightman, S; Maresh, M; Pring, DW | 1 |
| Faure, N; Fazekas, AT; Jean, C; Lemay, A; Maheux, R | 1 |
| Bastide, A; Fazekas, AT; Guilloteau, C; Lemay, A; Maheux, R | 1 |
| Ashitani, J; Ihi, T; Maki, H; Matsukura, S; Mukae, H; Sakamoto, A; Taniguchi, H; Ueno, H | 1 |
| Barrington, JW; Roberts, A | 1 |
| Van Leusden, HA | 1 |
| Burgut, R; Cetin, T; Demir, C; Vardar, MA | 1 |
| Bühler, K; Cirkel, U; Fuchs, U; Koch, R; Mettler, L; Ochs, H; Schindler, AE; Schweppe, KW | 1 |
| Katagiri, N; Minaguchi, H; Mohri, J; Osada, H; Suzuki, N; Uemura, T | 1 |
| Takahashi, K; Takata, K | 1 |
| Bernard, A; Curtis, P; Jackson, A; Shaw, RW | 1 |
| Fukushima, M; Sato, K; Shindo, M | 1 |
| Anthony, FW; Jenkins, JM; Masson, GM; Rushen, D; Thomas, E; Wood, P | 1 |
| Fukaya, T; Hoshiai, H; Ishikawa, M; Noda, K; Sawatari, Y | 1 |
| Cirkel, U; Mues, B; Ochs, H; Schneider, HP; Sorg, C; Zwadlo, G | 1 |
| Shaw, RW; Waller, KG | 1 |
| Bianchi, S; Bocciolone, L; Di Nola, G; Fedele, L; Franchi, D | 1 |
| Baglioni, A; Bianchi, S; Fedele, L; Marchini, M; Zanotti, F | 1 |
| Furuya, K; Hirata, J; Ishikawa, N; Kikuchi, Y; Makimura, N; Mitsui, C; Mizumoto, Y; Nagata, I; Tokuoka, S | 1 |
| Fukushima, M | 1 |
| Camus, M; Chedid, S; Devroey, P; Smitz, J; Van Steirteghem, AC | 1 |
| Batioğlu, S; Cağlar, T; Ciçek, N; Gökmen, O; Kuşçu, E; Ozakşit, G | 1 |
| Caruana, P; Mancuso, S; Marana, R; Muzii, L | 1 |
| Imaoka, I; Kitao, M; Okada, M; Okada, S; Sugimura, K; Takahashi, K | 1 |
| Furuya, K; Kimura, T; Makimura, N; Mitsui, C; Mizumoto, Y; Nagata, I; Seki, K | 1 |
| Furuya, K; Hirata, J; Kikuchi, Y; Mizumoto, Y; Nagata, I; Tokuoka, S | 1 |
| Batioglu, S; Celikkanat, H; Heberal, A | 1 |
| Cortés-Prieto, J; Keller, J; Nieto, A; Serra, M; Tacuri, C | 1 |
| Bier, UW; Bühler, K; Kato, K; Regidor, M; Regidor, PA; Schindler, AE | 1 |
| Morita, Y; Taketani, Y; Tsutsumi, O | 1 |
| Amama, EA; Minaguchi, H; Taga, M | 1 |
| Fuseya, T; Horibe, S; Imai, A; Takagi, A; Takagi, H; Tamaya, T | 1 |
| Aoki, D; Futamura, Y; Katsuki, Y; Nozawa, S; Shibutani, Y; Takano, Y; Udagawa, Y | 1 |
| Horibe, S; Imai, A; Takagi, A; Takagi, H; Tamaya, T | 1 |
| Donhuijsen, K; Leder, LD; Regidor, PA; Ruwe, M; Schindler, AE | 1 |
| Kawamura, N; Miyama, M; Mizuno, K; Ogita, S; Tanaka, T; Umesaki, N | 1 |
| Miyake, A; Mori, H; Taketani, Y; Tango, T; Uemura, T | 1 |
| Chang, SY; Hsu, TY; Huang, FJ; Kung, FT | 1 |
| Asukai, K; Hiroshi, M; Katagiri, N; Osada, H; Shirasu, K; Suzuki, N; Suzuki, T; Uemura, T | 1 |
| Anaf, V; El Nakadi, I; Englert, Y; Fayt, I; Noel, JC; Peny, MO; Simon, P | 1 |
| Imai, A; Takagi, A; Tamaya, T | 1 |
| Akoum, A; Boucher, A; Lemay, A | 1 |
| Ogita, S; Tanaka, T; Umesaki, N | 1 |
| Yu, N | 1 |
| Kikuchi, I; Kobori, H; Mitsuhashi, N; Sato, Y; Takeuchi, H | 1 |
| Fang, F; Huang, M | 1 |
| Choktanasiri, W; Rojanasakul, A | 1 |
| Beard, RW; Gangar, KF; Reid, BA | 1 |
| Matsuyama, A; Minaguchi, H; Shirasu, K; Uemura, T; Yanagisawa, T | 1 |
| Shaw, RW | 5 |
| Bocciolone, L; Bolis, G; Colombo, A; Rognoni, MT; Vendola, N; Vercellini, P | 1 |
| Gerhard, I; Postneek, F | 1 |
| Kuo, TM; Mizuno, M; Taketani, Y | 1 |
| Barnes, JF; Farish, E; Fletcher, CD; Gray, CE; Hart, DM; Mack, A | 1 |
| Clerckx, F; Donnez, J; Gillerot, S; Grandjean, P; Nisolle, M | 1 |
| Frank, RA; Miller, RM | 1 |
| Doesburg, WH; Franssen, AM; Rolland, R; Thomas, CM; van der Heijden, PF; Willemsen, WN | 1 |
| Reichel, RP; Schweppe, KW | 1 |
| Cowen, GM; Fraser, HM; Haining, R; Sandow, J; Smith, KB; Smith, SK | 1 |
| Bianchi, C; Bianchi, S; Bocciolone, L; Candiani, GB; Fedele, L; Parazzini, F; Radici, E | 1 |
| Asai, M; Masahashi, T; Nakanishi, M; Negoro, Y; Noguchi, M; Suzuki, M; Tomita, A | 1 |
| Bianchi, S; Brioschi, D; Fedele, L; Marchini, M; Parazzini, F; Villa, L | 1 |
| Inagaki, S; Kondou, I; Nakamura, K; Narita, O; Oosawa, M; Shibata, H; Suganuma, N; Tomoda, Y | 1 |
| Lemay, A; Lourdusamy, M | 1 |
| Chrisp, P; Goa, KL | 1 |
| Crijns, MB; Jansen, FW; van der Schroeff, JG; van Praag, MC | 1 |
| Fisher, L; Goulding, A | 1 |
| Dodin, S; Dumont, M; Lemay, A; Maheux, R; Turcot-Lemay, L | 1 |
| Ajossa, S; Fioretti, P; Guerriero, S; Mais, V; Melis, GB; Paoletti, AM | 1 |
| Armengol, J; Bella, F; Calaf, J; Espaulella, J; Lain, JM | 1 |
| De Vroey, P; Impens, N; Laureys, M; Schandevyl, W; Slabbynck, H | 1 |
| Cetera, C; de Laurentiis, G; Giorgino, FL | 1 |
| Biberoglu, K; Gursoy, R; Yildiz, A | 1 |
| Mettler, L; Schachner-Wünschmann, E; Steinmüller, H | 1 |
| Brideau, NA; Dodin, S; Forest, JC; Lemay, A; Maheux, R | 1 |
| Lauritzen, C; Rossmanith, WG; Sasse, V; Wirth, U | 1 |
| Chang, SP; Chao, HT; Chen, SC; Ng, HT; Tzeng, CR; Wei, TC; Yang, TS | 1 |
| Baba, K; Itoyama, S; Kinoshita, K; Kojima, T; Morita, Y; Sakamoto, S; Takeda, S | 1 |
| Fuchs, U; Zwirner, M | 2 |
| Balducci, M; Bulletti, C; Flamigni, C; Galassi, A; Jasonni, VM; Melega, C | 1 |
| Barbieri-Carones, M; Nencioni, T; Ortolani, S; Penotti, M; Polvani, F; Trevisan, C | 1 |
| Cirkel, U; Latussek, B; Ochs, H; Schneider, HP | 1 |
| Cowen, GM; Fraser, HM; Haining, R; Lumsden, MA; Sandow, J; Smith, SK | 1 |
| Dawood, MY; Dmowski, WP; Gambrell, RD; Girard, Y; Greenblatt, RB; Lemay, A; Mishell, DR; Nagamani, M; Pepperell, RJ; Spellacy, WN | 1 |
| de Looze, S; Trabant, H; Widdra, W | 1 |
| Casanas, F; Clerckx, F; Donnez, J; Nisolle, M | 1 |
| Gambone, JC; Judd, HL; Lu, JK; Surrey, ES | 1 |
| Cirkel, U; Ochs, H; Schneider, HP; Schweppe, KW | 3 |
| Anserini, P; Capitanio, GL; Costa, M; Croce, S; Ferraiolo, A; Remorgida, V | 1 |
| Chailurkit, LO; Rojanasakul, A; Sirimongkolkasem, R | 1 |
| Baglioni, A; Bianchi, S; Bocciolone, L; Fedele, L; Marchini, M; Nava, S | 1 |
| Ashkenazi, J; Dicker, D; Feldberg, D; Goldman, GA; Goldman, JA; Voliovitz, I | 1 |
| Abyholm, T; Dale, PO; Tanbo, T | 1 |
| De Boever, J; Serreyn, R; Vandekerckhove, D; Zweers, A | 1 |
| Bourgonjon, D; Casanas-Roux, F; Clerckx, F; Donnez, J; Gillerot, S; Nisolle, M | 1 |
| Echizenya, N; Fujii, S; Fukushi, A; Kagiya, A; Saito, Y; Tachizaki, T | 1 |
| Schenken, RS | 1 |
| Ding, YQ; Huhtaniemi, I; Jaakkola, T; Kellokumpu-Lehtinen, P; Martikainen, H; Rönnberg, L; Tapanainen, J; Valavaara, R | 1 |
| Raitz von Frentz, M; Schweppe, KW | 1 |
| Dowsett, M; Edmonds, DK; Maouris, P; Robertson, WR; Rose, G; Rothwell, C | 1 |
| Elstein, M; Golland, IM; Laing, I; Shalet, SM; Vaughan-Williams, CA | 1 |
| Anserini, P; Costantini, S; Cucuccio, S; de Cecco, L; Fasce, V; Venturini, PL | 1 |
| Caruso, A; Dell'Acqua, S; Lanzone, A; Mancuso, S; Marana, R; Muscatello, P; Muzii, L | 1 |
| Bianchi, C; Bocciolone, L; Candiani, GB; Fedele, L; Vercellini, P | 1 |
| Dawood, MY; Khan-Dawood, FS; Ramos, J | 1 |
| Binor, Z; Dmowski, WP; Pepping, P; Radwanska, E; Tummon, I | 1 |
| Bertges, K; Jerabek-Sandow, G; Kiesel, L; Runnebaum, B; Sandow, J; Trabant, H | 1 |
| Dawood, MY; Lewis, V; Ramos, J | 1 |
| Casanas-Roux, F; Clerckx-Braun, F; Donnez, J; Nisolle-Pochet, M; Sandow, J | 1 |
| Kitazawa, M; Kumasaka, T; Masaoka, K | 1 |
| Kitazawa, M; Kumasaka, T; Masaoka, K; Watanabe, H | 1 |
| Koskimies, A; Laatikainen, T; Ranta, T; Rönnberg, L; Saastamoinen, J | 1 |
| Crusius, M; Meinen, K; Schulz, U | 1 |
| Aono, T; Miyake, A; Mizutani, T; Ohtsuka, S; Sakata, M; Shimizu, I; Tanizawa, O; Terakawa, N | 1 |
| Castoldi, R; Di Carlo, V; Di Palo, S; Mari, G; Staudacher, C; Taccagni, G | 1 |
| Philipp, K; Reichel, R; Spona, J | 1 |
| Dodin Dewailly, S; Lemay, A | 1 |
| Cirkel, U; Hanker, JP; Ochs, H; Schneider, HP; Schweppe, KW | 1 |
| Lemay, A | 3 |
| Chadha, DR; Franssen, AM; Kauer, FM; Rolland, R; Zijlstra, JA | 1 |
| Litschgi, M | 1 |
| Erickson, LD; Ory, SJ | 1 |
| Arcaini, L; Bianchi, S; Candiani, GB; Fedele, L; Vercellini, P | 1 |
| Terakawa, N | 1 |
| Fuchs, U | 1 |
| Crook, D; Gardner, R; Nolan, J; Shaw, RW; Stevenson, JC; Worthington, M | 1 |
| Gardner, R; Lees, B; Shaw, RW; Stevenson, JC | 1 |
| Dowsett, M; Edmonds, DK; Maouris, P; Rose, G | 1 |
| Brosens, I; Buttram, VC; Cirkel, U; Franssen, AM; Lemay, A; Magill, P; Minaguchi, H; Sandow, J; Sugimoto, O; Yee, B | 1 |
| Fraser, HM; Geisthövel, F; Sandow, J | 1 |
| Burger, HG; Healy, DL; McLachlan, RI | 1 |
| Inoue, T; Kigawa, T; Matsuoka, R; Mori, H | 1 |
| Genz, T; Hardt, W; Nevinny-Stickel, J; Schmidt-Gollwitzer, K; Schmidt-Gollwitzer, M | 1 |
| Faure, N; Jean, C; Lemay, A; Maheux, R | 1 |
| Yee, B | 1 |
| Minaguchi, H; Shirasu, K; Uemura, T | 1 |
| Franssen, AM; Kauer, FM; Rolland, R; van 't Veen, AJ; Willemsen, WN; Zijlstra, JA | 1 |
| Jelley, RY; Magill, PJ | 1 |
| Matta, W; Shaw, RW | 1 |
| Chadha, DR; Franssen, AM; Rolland, R; Vemer, HM; Willemsen, WN | 1 |
| Baird, DT; Fraser, HM | 1 |
| Bureau, M; Faure, N; Lemay, A; Maheux, R; Mérat, P; Quesnel, G | 1 |
| Dmowski, WP; Henig, I; Rawlins, RG; Weinrib, HP | 1 |
| Blanchet, J; Faure, N; Huot, C; Lemay, A; Maheux, R | 1 |
| Bureau, M; Fontaine, JY; Lemay, A; Maheux, R; Mérat, P; Sandow, J | 1 |
| Casanas-Roux, F; Donnez, J; Nisolle-Pochet, M | 1 |
| Ali, A; Binor, Z; Dmowski, WP; Pepping, ME; Radwanska, E; Tummon, IS | 1 |
| D'Amico, JF; Dlugi, AM; Rufo, S; Seibel, MM | 1 |
| Hardt, W; Nevinny-Stickel, J; Schmidt-Gollwitzer, K; Schönegg, W; von Holleben, H | 1 |
| Okuda, K; Sugimoto, O; Ushiroyama, T; Yoshikawa, M | 1 |
| Evans, R; Hesp, R; Matta, WH; Shaw, RW | 1 |
| Sugimoto, O | 1 |
| Pepperell, RJ | 1 |
13 review(s) available for buserelin and Endometrioma
| Article | Year |
|---|---|
Treatment of endometriosis in different ethnic populations: a meta-analysis of two clinical trials.
Topics: Asian People; Buserelin; Endometriosis; Europe; Female; Hormone Antagonists; Humans; Japan; Leuprolide; Nandrolone; Treatment Outcome; White People | 2012 |
[Endometriosis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Buserelin; Combined Modality Therapy; Danazol; Drug Therapy, Combination; Endometriosis; Estrogens; Evidence-Based Medicine; Female; Gonadotropin-Releasing Hormone; Humans; Laparoscopy; Nafarelin | 2006 |
[Pulmonary endometriosis with recurrent catamenial hemoptysis].
Topics: Adult; Buserelin; Endometriosis; Female; Hemoptysis; Humans; Lung Diseases; Menstrual Cycle; Recurrence | 1995 |
Impact of different GnRH analogs in benign gynecological disorders related to their chemical structure, delivery systems and dose.
Topics: Buserelin; Dose-Response Relationship, Drug; Drug Delivery Systems; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Leuprolide; Menstrual Cycle; Nafarelin; Structure-Activity Relationship; Triptorelin Pamoate | 1994 |
[Prevention and therapy of side effects of gonadotropin-releasing hormone agonist in patients with endometriosis].
Topics: Buserelin; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Nafarelin; Osteoporosis | 1999 |
Zoladex (goserelin) in the treatment of benign gynaecological disorders: an overview of safety and efficacy.
Topics: Buserelin; Endometriosis; Female; Goserelin; Humans; Leiomyoma; Uterine Neoplasms | 1992 |
Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use in sex hormone-related conditions.
Topics: Animals; Breast Neoplasms; Buserelin; Drug Evaluation; Endometriosis; Female; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Gonadotropins; Goserelin; Humans; Leiomyoma; Male; Menstruation Disturbances; Polycystic Ovary Syndrome; Prostatic Neoplasms; Uterine Neoplasms | 1991 |
Efficacy and safety of intranasal buserelin acetate in the treatment of endometriosis: a review of six clinical trials and comparison with danazol.
Topics: Administration, Intranasal; Buserelin; Climacteric; Clinical Trials as Topic; Danazol; Endometriosis; Estradiol; Female; Humans; Infertility, Female; Ovulation; Pregnadienes; Pregnancy; Randomized Controlled Trials as Topic; Safety | 1990 |
GnRH analogues in the treatment of endometriosis.
Topics: Buserelin; Danazol; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Nafarelin; Pituitary Hormone-Releasing Hormones | 1989 |
Pharmacology and experimental basis of therapy with LHRH agonists in women.
Topics: Administration, Intranasal; Animals; Buserelin; Endometriosis; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Kinetics; Mammary Neoplasms, Experimental; Ovary; Receptors, LHRH | 1986 |
Clinical aspects of LHRH analogues in gynaecology: a review.
Topics: Adolescent; Adult; Breast Neoplasms; Buserelin; Clinical Trials as Topic; Contraceptive Agents, Female; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormones; Humans; Hypogonadism; Infertility, Female; Leiomyoma; Menstruation Disturbances; Pituitary Gland; Polycystic Ovary Syndrome; Uterine Neoplasms | 1986 |
Efficacy of different modalities of LHRH agonist (buserelin) administration on the inhibition of the pituitary-ovarian axis for the treatment of endometriosis.
Topics: Administration, Intranasal; Buserelin; Endometriosis; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Humans; Injections, Subcutaneous; Luteinizing Hormone; Ovary; Pituitary Gland | 1986 |
Clinical applications of LHRH analogues.
Topics: Administration, Intranasal; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Drug Therapy, Combination; Endometriosis; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Leiomyoma; Male; Ovulation; Ovulation Induction; Premenstrual Syndrome; Prostatic Neoplasms; Puberty, Precocious; Uterine Neoplasms; Uterus | 1987 |
42 trial(s) available for buserelin and Endometrioma
| Article | Year |
|---|---|
Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial.
Topics: Abdominal Pain; Administration, Intranasal; Administration, Oral; Bone Density; Buserelin; Double-Blind Method; Dyspareunia; Endometriosis; Female; Humans; Japan; Low Back Pain; Nandrolone; Pain; Pain Measurement; Treatment Outcome | 2009 |
Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
Topics: Adult; Buserelin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Pelvic Pain; Prospective Studies; Time Factors; Treatment Outcome; Uterine Hemorrhage | 2011 |
[Treatment of endometriosis with the GnRH agonist buserelin (Suprecur): a multicenter study].
Topics: Administration, Intranasal; Adolescent; Adult; Buserelin; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Drug Administration Schedule; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Laparoscopy; Luteinizing Hormone; Middle Aged; Progesterone; Prospective Studies | 1994 |
Effect of gonadotropin-releasing hormone agonist on the bone mineral density of patients with endometriosis.
Topics: Adult; Bone and Bones; Bone Density; Buserelin; Endometriosis; Female; Gonadal Steroid Hormones; Humans; Prospective Studies; Regression Analysis | 1994 |
Hormone treatment related bone mineral content changes in Japanese women with endometriosis.
Topics: Adult; Bone Density; Buserelin; Danazol; Endometriosis; Female; Humans; Japan; Middle Aged; Single-Blind Method | 1993 |
The development of functional ovarian cysts during pituitary down-regulation.
Topics: Adult; Buserelin; Down-Regulation; Endometriosis; Female; Fertilization in Vitro; Humans; Ovarian Cysts; Pituitary Gland; Progesterone | 1993 |
Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up.
Topics: Adolescent; Adult; Buserelin; Endometriosis; Female; Follow-Up Studies; Goserelin; Humans; Middle Aged; Nafarelin; Prospective Studies; Recurrence | 1993 |
Buserelin acetate in the treatment of pelvic pain associated with minimal and mild endometriosis: a controlled study.
Topics: Buserelin; Dysmenorrhea; Endometriosis; Female; Humans; Pain; Pelvis | 1993 |
Vaginal patterns during danazol and buserelin acetate therapy for endometriosis: structural and ultrastructural study.
Topics: Biopsy; Buserelin; Danazol; Endometriosis; Estradiol; Female; Humans; Microscopy, Electron, Scanning; Progesterone; Vagina | 1993 |
Changes in bone mineral content following hormone treatment for endometriosis.
Topics: Adult; Alkaline Phosphatase; Bone Density; Buserelin; Creatinine; Danazol; Endometriosis; Estradiol; Female; Humans; Hydroxyproline; Middle Aged; Osteocalcin; Single-Blind Method | 1995 |
The impact of preoperative gonadotropin-releasing hormone agonist treatment on laparoscopic excision of ovarian endometriotic cysts.
Topics: Adult; Buserelin; Endometriosis; Female; Humans; Ovarian Cysts; Preoperative Care; Recurrence | 1996 |
Long-term follow-up of endometriosis after two different therapies (Gestrinone and Buserelin).
Topics: Adult; Buserelin; Endometriosis; Female; Follow-Up Studies; Gestrinone; Humans; Progesterone Congeners; Prospective Studies; Recurrence; Remission Induction; Uterine Diseases | 1996 |
[Endometriosis: clinical, histological and morphometric findings before and after Gn-RH agonist therapy].
Topics: Adult; Buserelin; Dose-Response Relationship, Drug; Endometriosis; Fallopian Tubes; Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Treatment Outcome | 1998 |
A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis.
Topics: Adult; Antineoplastic Agents, Hormonal; Buserelin; Endometriosis; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Leiomyoma; Leuprolide; Luteinizing Hormone; Male; Middle Aged; Ovarian Diseases; Prospective Studies; Treatment Outcome; Ultrasonography; Uterine Diseases; Uterine Hemorrhage | 2000 |
An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Zoladex Endometriosis Study Team.
Topics: Adolescent; Adult; Buserelin; Danazol; Delayed-Action Preparations; Endometriosis; Female; Goserelin; Humans; Menstruation; Pregnancy | 1992 |
On the origin and significance of serum CA-125 concentrations in 97 patients with endometriosis before, during, and after buserelin acetate, nafarelin, or danazol.
Topics: Antigens, Tumor-Associated, Carbohydrate; Buserelin; Danazol; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Menstrual Cycle; Nafarelin; Osmolar Concentration; Retrospective Studies; Tissue Adhesions | 1992 |
Buserelin acetate versus expectant management in the treatment of infertility associated with minimal or mild endometriosis: a randomized clinical trial.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Clomiphene; Endometriosis; Female; Humans; Infertility, Female; Ovulation Induction; Pregnancy | 1992 |
Superovulation with human menopausal gonadotropins in the treatment of infertility associated with minimal or mild endometriosis: a controlled randomized study.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Endometriosis; Female; Humans; Infertility, Female; Menotropins; Prospective Studies; Superovulation | 1992 |
Treatment of estrogen-dependent gynecological disorders with the gonadotropin releasing hormone agonist buserelin.
Topics: Administration, Intranasal; Adult; Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Blood Proteins; Blood Urea Nitrogen; Bone Density; Buserelin; Endometriosis; Estrogens; Female; Follicle Stimulating Hormone; Humans; Laparoscopy; Leiomyoma; Lipids; Luteinizing Hormone; Menstruation; Progesterone; Prolactin; Serum Albumin; Uterine Neoplasms | 1991 |
Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol.
Topics: Adult; Apolipoproteins; Buserelin; Cholesterol, HDL; Cholesterol, LDL; Danazol; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans | 1991 |
Gonadotropin releasing hormone agonist therapy and its effect on bone mass.
Topics: Adult; Amenorrhea; Bone Density; Buserelin; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Middle Aged; Time Factors; Uterine Neoplasms | 1991 |
Efficacy and safety of intranasal buserelin acetate in the treatment of endometriosis: a review of six clinical trials and comparison with danazol.
Topics: Administration, Intranasal; Buserelin; Climacteric; Clinical Trials as Topic; Danazol; Endometriosis; Estradiol; Female; Humans; Infertility, Female; Ovulation; Pregnadienes; Pregnancy; Randomized Controlled Trials as Topic; Safety | 1990 |
Evaluation of preoperative use of danazol, gestrinone, lynestrenol, buserelin spray and buserelin implant, in the treatment of endometriosis associated infertility.
Topics: Adult; Buserelin; Clinical Trials as Topic; Danazol; Endometriosis; Female; Gestrinone; Humans; Infertility, Female; Lynestrenol; Pregnancy; Preoperative Care; Prospective Studies; Steroids | 1990 |
Endometrial patterns during danazol and buserelin therapy for endometriosis: comparative structural and ultrastructural study.
Topics: Adult; Buserelin; Danazol; Endometriosis; Endometrium; Estradiol; Female; Humans; Microscopy, Electron, Scanning; Organelles; Pregnadienes; Progesterone; Randomized Controlled Trials as Topic | 1990 |
Correlation between peripheral CA-125 levels and ovarian activity.
Topics: Antigens, Tumor-Associated, Carbohydrate; Buserelin; Chorionic Gonadotropin; Clinical Trials as Topic; Clomiphene; Endometriosis; Female; Fertilization in Vitro; Humans; Menstrual Cycle; Ovary; Ovulation | 1990 |
Goserelin--depot preparation of LHRH analogue used in the treatment of endometriosis.
Topics: Buserelin; Chemistry, Pharmaceutical; Delayed-Action Preparations; Endocrine Glands; Endometriosis; Female; Goserelin; Humans; Multicenter Studies as Topic; Safety | 1990 |
The effect of danazol and the LHRH agonist analogue goserelin (Zoladex) on the biological activity of luteinizing hormone in women with endometriosis.
Topics: Adult; Buserelin; Danazol; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone | 1990 |
Influence of danazol and goserelin on insulin and glucagon in non-obese women with endometriosis.
Topics: Adult; Androgens; Blood Glucose; Buserelin; C-Peptide; Danazol; Endometriosis; Female; Follicle Stimulating Hormone; Glucagon; Glucose Tolerance Test; Goserelin; Humans; Insulin; Luteinizing Hormone; Testosterone | 1990 |
[Goserelin depot: an analog of LHRH for the treatment of endometriosis].
Topics: Buserelin; Danazol; Delayed-Action Preparations; Endometriosis; Female; Goserelin; Humans | 1990 |
Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: a randomized, comparative study.
Topics: Adult; Buserelin; Danazol; Endometriosis; Female; Hormones; Humans; Menstruation; Ovary; Pelvic Neoplasms; Pregnadienes; Prognosis; Prospective Studies; Random Allocation | 1989 |
Administration of nasal Buserelin as compared with subcutaneous Buserelin implant for endometriosis.
Topics: Administration, Intranasal; Adult; Biopsy; Buserelin; Drug Implants; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Ovarian Neoplasms; Progesterone; Prospective Studies; Random Allocation | 1989 |
Efficacy of gonadotropin-releasing hormone agonist (buserelin) in the treatment of endometriosis.
Topics: Administration, Intranasal; Adult; Buserelin; Clinical Trials as Topic; Endometriosis; Female; Follow-Up Studies; Hormones; Humans; Multicenter Studies as Topic; Pregnancy | 1989 |
Buserelin versus danazol in the treatment of endometriosis-associated infertility.
Topics: Adult; Buserelin; Danazol; Endometriosis; Estradiol; Female; Follow-Up Studies; Humans; Infertility, Female; Laparoscopy; Menstruation; Pregnadienes; Progesterone; Random Allocation; Recurrence | 1989 |
Clinical aspects of LHRH analogues in gynaecology: a review.
Topics: Adolescent; Adult; Breast Neoplasms; Buserelin; Clinical Trials as Topic; Contraceptive Agents, Female; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormones; Humans; Hypogonadism; Infertility, Female; Leiomyoma; Menstruation Disturbances; Pituitary Gland; Polycystic Ovary Syndrome; Uterine Neoplasms | 1986 |
A preliminary report on the comparative use of buserelin (Hoe 766) and danazol in the treatment of endometriosis: the University of Southern California experience.
Topics: Adult; Buserelin; Clinical Trials as Topic; Danazol; Endometriosis; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Pregnadienes | 1986 |
Effect of LH-RH agonist therapy in the treatment of endometriosis (German experience).
Topics: Adult; Buserelin; Clinical Trials as Topic; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Lipids; Liver; Luteinizing Hormone | 1986 |
Clinical study on finding optimal dose of a potent LHRH agonist (buserelin) for the treatment of endometriosis--multicenter trial in Japan.
Topics: Adult; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Buserelin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Ovary; Ovulation; Pituitary Gland; Prolactin | 1986 |
The effect of LHRH agonist therapy in the treatment of endometriosis (Dutch experience).
Topics: Adolescent; Adult; Buserelin; Clinical Trials as Topic; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Infertility, Female; Luteinizing Hormone; Uterine Hemorrhage | 1986 |
The effect of LHRH agonist therapy in the treatment of endometriosis (English experience).
Topics: Adolescent; Adult; Amenorrhea; Buserelin; Clinical Trials as Topic; Danazol; Endometriosis; Female; Humans; Pregnadienes; Prospective Studies; Random Allocation | 1986 |
Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis.
Topics: Administration, Intranasal; Adult; Buserelin; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Injections, Subcutaneous; Luteinizing Hormone; Ovary; Pelvic Neoplasms; Time Factors | 1988 |
Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women.
Topics: Adult; Bone and Bones; Buserelin; Endometriosis; Female; Femur; Humans; Lumbar Vertebrae; Menopause; Minerals; Ovary | 1988 |
Will gonadotrophin releasing hormone analogues profoundly affect gynaecological practice?
Topics: Amenorrhea; Buserelin; Clinical Trials as Topic; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Male; Ovulation; Prostatic Neoplasms; Uterine Neoplasms | 1985 |
123 other study(ies) available for buserelin and Endometrioma
| Article | Year |
|---|---|
Catamenial pneumothorax: a cause of monthly breathlessness.
Topics: Adult; Buserelin; Dyspnea; Endometriosis; Female; Humans; Menstruation; Pleural Diseases; Pneumothorax; Thoracoscopy | 2019 |
Efficacy of long-term, low-dose gonadotropin-releasing hormone agonist therapy (draw-back therapy) for adenomyosis.
Topics: Absorptiometry, Photon; Analysis of Variance; Bone Density; Buserelin; CA-125 Antigen; Dose-Response Relationship, Drug; Endometriosis; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Lumbar Vertebrae; Retrospective Studies; Treatment Outcome | 2009 |
Successful long-term management of adenomyosis associated with deep thrombosis by low-dose gonadotropin-releasing hormone agonist therapy.
Topics: Administration, Intranasal; Adult; Buserelin; Drug Administration Schedule; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Venous Thrombosis | 2009 |
Gonadotropin-releasing hormone analogues reduce the proliferation of endometrial stromal cells but not endometriotic cells.
Topics: Adult; Blotting, Western; Buserelin; Cell Proliferation; Endometriosis; Endometrium; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression; Gonadotropin-Releasing Hormone; Humans; Interleukin-8; Leiomyoma; Ovarian Diseases; Premenopause; Receptors, LHRH; Stromal Cells; Tumor Necrosis Factor-alpha; Uterine Neoplasms | 2013 |
Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas.
Topics: Adult; Antineoplastic Agents, Hormonal; Aromatase; Buserelin; Danazol; Endometriosis; Estrogen Antagonists; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; In Vitro Techniques; Ki-67 Antigen; Leiomyoma; Leuprolide; Middle Aged; Prospective Studies; Receptors, Estrogen; Receptors, Progesterone; RNA, Neoplasm; Uterine Diseases; Uterine Neoplasms | 2003 |
Long-term effects on bone mineral density and bone metabolism of 6 months' treatment with gonadotropin-releasing hormone analogues in Japanese women: comparison of buserelin acetate with leuprolide acetate.
Topics: Absorptiometry, Photon; Adult; Bone and Bones; Bone Density; Buserelin; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Japan; Leuprolide; Lumbar Vertebrae; Osteocalcin; Osteoporosis; Time Factors; Uterus | 2005 |
Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist.
Topics: Adult; Aromatase Inhibitors; Buserelin; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Magnetic Resonance Imaging; Premenopause; Uterine Diseases | 2007 |
[Endometriosis].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Buserelin; Complementary Therapies; Contraceptive Agents, Female; Cyclooxygenase 2 Inhibitors; Dysmenorrhea; Endometriosis; Female; Fertility Agents, Female; Humans; Infertility, Female; Leuprolide; Medroxyprogesterone Acetate; Middle Aged; Postoperative Care; Pregnancy; Time Factors | 2007 |
Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist.
Topics: Administration, Intranasal; Adult; Buserelin; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Laparoscopy; Luteinizing Hormone | 1982 |
Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis.
Topics: Adult; Buserelin; Creatinine; Endometriosis; Estrogens; Female; Humans; Menstruation; Nose; Ovulation; Pregnanediol | 1983 |
Luteinising hormone releasing hormone agonist in women with endometriosis.
Topics: Buserelin; Endometriosis; Female; Humans | 1983 |
Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis.
Topics: Adolescent; Adult; Biopsy; Buserelin; Depression, Chemical; Endometriosis; Endometrium; Estradiol; Female; Flushing; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Ovulation; Pelvic Neoplasms; Time Factors; Uterine Hemorrhage | 1984 |
Regression of leiomyomata uteri following hypoestrogenism induced by repetitive luteinizing hormone-releasing hormone agonist treatment: preliminary report.
Topics: Adult; Buserelin; Endometriosis; Estradiol; Estrogens; Female; Follicle Stimulating Hormone; Humans; Leiomyoma; Luteinizing Hormone; Progesterone; Ultrasonics; Uterine Neoplasms | 1984 |
Acute renal failure precipitated by luteinizing-hormone releasing hormone analogue for the treatment of endometriosis.
Topics: Acute Kidney Injury; Buserelin; Endometriosis; Female; Humans; Middle Aged | 1994 |
Etiology of serum CA-125 in patients with endometriosis treated with a gonadotrophin-releasing hormone agonist (Buserelin).
Topics: Buserelin; CA-125 Antigen; Endometriosis; Estradiol; Female; Humans; Radioimmunoassay | 1994 |
Cyclic sciatica. A case report.
Topics: Adult; Buserelin; Diagnosis, Differential; Endometriosis; Female; Humans; Periodicity; Sciatica; Tomography, X-Ray Computed | 1994 |
Pretreatment with gonadotrophin releasing hormone (GnRH) analogue prior to in vitro fertilisation for patients with endometriosis.
Topics: Adult; Buserelin; Endometriosis; Female; Fertilization in Vitro; Humans; Middle Aged; Pregnancy; Retrospective Studies | 1993 |
Laparoscopic evaluation of the onset and progression of endometriosis.
Topics: Adolescent; Adult; Buserelin; Colorectal Neoplasms; Danazol; Endometriosis; Fallopian Tube Neoplasms; Female; Fertility; Humans; Infertility; Laparoscopy; Ovarian Neoplasms; Pelvic Neoplasms; Retrospective Studies; Uterine Neoplasms | 1993 |
Inflammatory reaction in endometriotic tissue: an immunohistochemical study.
Topics: Adult; Antibodies, Monoclonal; Biopsy; Buserelin; Contraceptives, Oral, Hormonal; Danazol; Endometriosis; Endometritis; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Immunoglobulin G; Immunoglobulin M; Immunohistochemistry; Norgestrel | 1993 |
[The effect of danazol and buserelin on natural killer activity in experimental endometriosis of the rat].
Topics: Animals; Buserelin; Cells, Cultured; Cytotoxicity, Immunologic; Danazol; Disease Models, Animal; Endometriosis; Female; Killer Cells, Natural; Rats; Rats, Wistar; Spleen | 1995 |
Comparison among different ovarian stimulation regimens for assisted procreation procedures in patients with endometriosis.
Topics: Adult; Buserelin; Cleavage Stage, Ovum; Clomiphene; Cryopreservation; Embryo Implantation; Endometriosis; Female; Fertilization in Vitro; Gamete Intrafallopian Transfer; Humans; Infertility, Female; Menotropins; Ovulation Induction; Pregnancy; Pregnancy, Ectopic; Pregnancy, Multiple; Retrospective Studies; Zygote Intrafallopian Transfer | 1995 |
Serum CA 125 levels before, during and after treatment for endometriosis.
Topics: Buserelin; CA-125 Antigen; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Predictive Value of Tests; Recurrence; Sensitivity and Specificity; Treatment Outcome | 1995 |
Prognostic application of magnetic resonance imaging in patients with endometriomas treated with gonadotrophin-releasing hormone analogue.
Topics: Adult; Buserelin; Endometriosis; Female; Humans; Laparoscopy; Magnetic Resonance Imaging; Prognosis | 1996 |
Gene expression of oxytocin receptor in human ectopic endometrial tissues.
Topics: Actins; Buserelin; Endometriosis; Endometrium; Female; Gene Expression; Humans; Ovarian Diseases; Pregnancy; Receptors, Oxytocin | 1995 |
Effect of culture supernatants of endometriotic lesions, uterine endometrium and peritoneum from rats with experimental endometriosis on the natural killer activity of spleen cells.
Topics: Animals; Buserelin; Culture Media, Conditioned; Culture Techniques; Danazol; Endometriosis; Endometrium; Estrogen Antagonists; Female; Killer Cells, Natural; Peritoneum; Rats; Rats, Wistar; Spleen | 1996 |
The adjuvant effect of oxytocin on GnRH analogue buserelin.
Topics: Adult; Antineoplastic Agents, Hormonal; Buserelin; Drug Synergism; Drug Therapy, Combination; Endometriosis; Female; Humans; Oxytocin | 1996 |
Long-term follow-up on the treatment of endometriosis with the GnRH-agonist buserelinacetate. Long-term follow-up data (up to 98 months) of 42 patients with endometriosis who were treated with GnRH-agonist buserelinacetate (Suprecur), were evaluated in re
Topics: Adult; Buserelin; Endometriosis; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Incidence; Infertility, Female; Pelvic Pain; Pregnancy; Pregnancy Outcome; Receptors, LHRH; Recurrence; Surveys and Questionnaires; Time Factors; Treatment Outcome | 1997 |
Successful hormonal treatment of pulmonary parenchymal endometriosis.
Topics: Adult; Antineoplastic Agents, Hormonal; Buserelin; Danazol; Endometriosis; Estrogen Antagonists; Female; Hemoptysis; Humans; Lung Diseases | 1997 |
The effect of gonadotropin-releasing hormone agonist on type I collagen C-telopeptide and N-telopeptide: the predictive value of biochemical markers of bone turnover.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Antineoplastic Agents, Hormonal; Biomarkers; Bone Remodeling; Buserelin; Collagen; Collagen Type I; Endometriosis; Estradiol; Female; Goserelin; Humans; Hydroxyproline; Leiomyoma; Osteocalcin; Peptides; Retrospective Studies | 1998 |
A gonadotropin-releasing hormone analogue impairs glucose tolerance in a diabetic patient.
Topics: Adult; Blood Glucose; Buserelin; Danazol; Diabetes Mellitus, Type 1; Endometriosis; Estrogen Antagonists; Female; Glycated Hemoglobin; Humans | 1998 |
Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats.
Topics: Animals; Buserelin; Cell Division; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytotoxicity, Immunologic; Danazol; Disease Models, Animal; Endometriosis; Enzyme Inhibitors; Estradiol; Female; Immunity, Cellular; Interleukin-1; Killer Cells, Natural; Macrophages, Peritoneal; Nandrolone; Progesterone; Progesterone Congeners; Protein Kinase C; Rats; Rats, Sprague-Dawley | 1998 |
Drastic elevation of serum CA125, CA72-4 and CA19-9 levels during menses in a patient with probable endometriosis.
Topics: Adnexal Diseases; Adult; Antigens, Tumor-Associated, Carbohydrate; Buserelin; CA-125 Antigen; CA-19-9 Antigen; Cysts; Endometriosis; Female; Humans; Luteal Phase; Menstrual Cycle | 1998 |
Increased natural killer cell activities in patients treated with gonadotropin releasing hormone agonist.
Topics: Adult; Buserelin; Endometriosis; Estradiol; Female; Humans; Killer Cells, Natural; Middle Aged | 1999 |
Rates of endometriosis recurrence and pregnancy 1 year after treatment with intranasal buserelin acetate (Suprecur) (a prospective study).
Topics: Administration, Intranasal; Adult; Buserelin; Disease-Free Survival; Endometriosis; Female; Fertility; Fertility Agents, Female; Humans; Japan; Middle Aged; Pregnancy; Pregnancy Rate; Prospective Studies; Recurrence; Surveys and Questionnaires | 1999 |
Effects of short-course buserelin therapy on adenomyosis. A report of two cases.
Topics: Administration, Intranasal; Adult; Antineoplastic Agents, Hormonal; Buserelin; Drug Administration Schedule; Endometriosis; Female; Humans; Pregnancy; Treatment Outcome | 1999 |
Low-dose GnRH agonist therapy for the management of endometriosis.
Topics: Abdominal Pain; Absorptiometry, Photon; Administration, Intranasal; Adult; Bone Density; Buserelin; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Lumbar Vertebrae; Luteinizing Hormone; Middle Aged | 1999 |
Sigmoid endometriosis and ovarian stimulation.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Digestive System Diseases; Endometriosis; Female; Fertilization in Vitro; Humans; Immunohistochemistry; Infertility, Female; Ki-67 Antigen; Menotropins; Ovulation Induction; Receptors, Steroid; Sigmoid Diseases | 2000 |
Gonadotropin-releasing hormone analog repairs reduced endometrial cell apoptosis in endometriosis in vitro.
Topics: Apoptosis; Benzimidazoles; Buserelin; Coloring Agents; DNA Fragmentation; Endometriosis; Endometrium; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Dyes; Humans; Leuprolide; Propidium | 2000 |
Effect of hormonal agents on monocyte chemotactic protein-1 expression by endometrial epithelial cells of women with endometriosis.
Topics: Adult; Blotting, Northern; Buserelin; Cells, Cultured; Chemokine CCL2; Danazol; Dexamethasone; Dose-Response Relationship, Drug; Endometriosis; Endometrium; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Female; Fertility Agents, Female; Glucocorticoids; Gonadotropin-Releasing Hormone; Humans; RNA, Messenger; Testosterone | 2000 |
Altered sensitivity to anti-endometriosis medicines in an adenomyosis patient with thyroid dysfunction.
Topics: Adult; Buserelin; CA-125 Antigen; Cinnamomum zeylanicum; Danazol; Endometriosis; Estrogen Antagonists; Female; Hormones; Humans; Hyperthyroidism; Japan; Leuprolide; Magnoliopsida; Medicine, East Asian Traditional; Nafarelin; Phytotherapy; Plant Extracts; Thyrotropin; Thyroxine; Triiodothyronine | 2000 |
Dosage of buserelin.
Topics: Administration, Inhalation; Aerosols; Buserelin; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans | 2000 |
Buserelin acetate implants in the treatment of pain in endometriosis.
Topics: Absorptiometry, Photon; Adult; Bone Density; Buserelin; Drug Implants; Endometriosis; Female; Humans; Pain; Treatment Outcome | 2001 |
Severe endometriosis treated with gonadotrophin releasing hormone agonist and continuous combined hormone replacement therapy.
Topics: Adult; Buserelin; Drug Therapy, Combination; Endometriosis; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Goserelin; Humans; Medroxyprogesterone; Pelvic Neoplasms | 1992 |
Mechanisms involved in the pituitary desensitization induced by gonadotropin-releasing hormone agonists.
Topics: Animals; Buserelin; Cells, Cultured; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Leuprolide; Luteinizing Hormone; Male; Nafarelin; Pituitary Gland; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, LHRH; RNA, Messenger | 1992 |
Laparoscopic aspiration of ovarian endometriomas. Effect with postoperative gonadotropin releasing hormone agonist treatment.
Topics: Adult; Analysis of Variance; Biopsy, Needle; Buserelin; Endometriosis; Female; Goserelin; Humans; Laparoscopy; Ovarian Neoplasms; Prospective Studies; Suction; Ultrasonography | 1992 |
Auricular acupuncture in the treatment of female infertility.
Topics: Acupuncture Therapy; Adult; Bromocriptine; Buserelin; Clomiphene; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dexamethasone; Ear; Endometriosis; Estradiol; Female; Gonadotropins; Humans; Infertility, Female; Pregnancy; Thyrotropin; Thyroxine | 1992 |
Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis.
Topics: Adult; Animals; Ascitic Fluid; Buserelin; Culture Techniques; Danazol; Embryonic and Fetal Development; Endometriosis; Fallopian Tubes; Female; Humans; Infertility, Female; Interleukin-1; Mice; Mice, Inbred ICR; Tumor Necrosis Factor-alpha | 1992 |
Reversible menopause induced by the GnRH analogue buserelin: effects on lipoprotein metabolism.
Topics: Adult; Apolipoproteins A; Apolipoproteins B; Buserelin; Coronary Disease; Endometriosis; Female; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Menopause; Middle Aged; Radioimmunoassay; Risk Factors; Time Factors | 1992 |
The place of GnRH agonists in the treatment of endometriosis and fibroids by advanced endoscopic techniques.
Topics: Adult; Buserelin; Combined Modality Therapy; Endometriosis; Female; Goserelin; Humans; Hysteroscopy; Leiomyoma; Myometrium; Ovarian Neoplasms; Prospective Studies; Uterine Neoplasms | 1992 |
Goserelin (Zoladex) depot in the treatment of endometriosis. Zoladex Endometriosis Study Group.
Topics: Adult; Buserelin; Delayed-Action Preparations; Endometriosis; Female; Gonadal Steroid Hormones; Goserelin; Humans; Pregnancy; Uterine Hemorrhage | 1992 |
Long-acting gonadotrophin releasing hormone agonist implant causes variable duration of suppression of ovarian steroid and inhibin secretion.
Topics: Adult; Buserelin; Drug Implants; Endometriosis; Female; Follicle Stimulating Hormone; Half-Life; Humans; Inhibins; Ovary; Time Factors | 1992 |
[Bone mineral content in premenopausal women treated with gonadotropin-releasing hormone analogue].
Topics: Adult; Alkaline Phosphatase; Bone Density; Buserelin; Calcitonin; Calcium; Endometriosis; Female; Humans; Middle Aged; Osteocalcin; Parathyroid Hormone; Uterine Neoplasms | 1992 |
Menotropin stimulation after prolonged gonadotropin releasing hormone agonist pretreatment for in vitro fertilization in patients with endometriosis.
Topics: Adult; Antigens, Tumor-Associated, Carbohydrate; Buserelin; Endometriosis; Female; Fertilization in Vitro; Humans; Infertility, Female; Menotropins; Ovulation Induction; Pregnancy; Treatment Outcome | 1992 |
Gonadotrophin releasing hormone agonist suppressive treatment of ovarian function decreases serum LH-beta and bioactive LH but maintains elevated levels of LH-alpha.
Topics: Adult; Buserelin; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Glycoprotein Hormones, alpha Subunit; Humans; Luteinizing Hormone; Ovary | 1991 |
Immediate-type reaction to buserelin acetate in a nasal spray.
Topics: Adult; Aerosols; Buserelin; Drug Hypersensitivity; Endometriosis; Female; Humans; Hypersensitivity, Immediate | 1991 |
Preventive effects of clomiphene citrate on estrogen-deficiency osteopenia elicited by LHRH agonist administration in the rat.
Topics: Animals; Bone Diseases, Metabolic; Bone Resorption; Buserelin; Calcium; Clomiphene; Endometriosis; Estrogens; Female; Gonadotropin-Releasing Hormone; Hydroxyproline; Rats; Rats, Inbred Strains; Uterus | 1991 |
Bone mass in endometriosis patients treated with GnRH agonist implant or danazol.
Topics: Adult; Alkaline Phosphatase; Bone Density; Buserelin; Danazol; Drug Implants; Endometriosis; Estradiol; Female; Femur Neck; Follow-Up Studies; Genital Neoplasms, Female; Goserelin; Humans; Random Allocation; Spine | 1991 |
Efficacy and endocrine effects of medical treatment of endometriosis.
Topics: Adolescent; Adult; Buserelin; Danazol; Endometriosis; Female; Follicle Stimulating Hormone; Gestrinone; Humans; Hypothalamus; Laparoscopy; Luteinizing Hormone; Middle Aged; Pituitary Gland; Progesterone | 1991 |
Pulmonary endometriosis: conservative treatment with GnRH agonists.
Topics: Administration, Intranasal; Adult; Antineoplastic Agents; Buserelin; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hemoptysis; Hormones; Humans; Leuprolide; Lung Neoplasms; Pneumothorax; Triptorelin Pamoate | 1991 |
Recurring catamenial pneumothorax treated with a Gn-RH analogue.
Topics: Adult; Buserelin; Endometriosis; Female; Goserelin; Humans; Menstruation; Pleural Neoplasms; Pneumothorax; Recurrence | 1991 |
Goserelin versus danazol in the treatment of endometriosis.
Topics: Bone Density; Buserelin; Danazol; Endometriosis; Female; Goserelin; Humans; Pelvic Neoplasms | 1991 |
Experience with a depot GnRH-agonist (Zoladex) in the treatment of genital endometriosis.
Topics: Adult; Buserelin; Delayed-Action Preparations; Endometriosis; Estradiol; Female; Goserelin; Humans; Luteinizing Hormone; Pregnancy; Pregnancy Outcome; Progesterone; Prolactin; Testosterone | 1991 |
[Differential effects of GnRH analogs on androgen concentrations in females].
Topics: Adult; Androgens; Antineoplastic Agents; Buserelin; Drug Implants; Endometriosis; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; Humans; Injections, Intramuscular; Leiomyoma; Luteinizing Hormone; Triptorelin Pamoate; Uterine Neoplasms | 1991 |
Buserelin treatment of endometriosis in Chinese women.
Topics: Adult; Buserelin; Endometriosis; Estradiol; Female; Follow-Up Studies; Humans; Laparoscopy | 1991 |
[Effects of buserelin presurgical treatment on vascularity in the sub-serosal interstitial tissue of the uterus and operative blood loss at hysterectomy in women with uterine leiomyoma and adenomyosis].
Topics: Blood Loss, Surgical; Buserelin; Danazol; Endometriosis; Female; Humans; Hysterectomy; Leiomyoma; Mucous Membrane; Preoperative Care; Uterine Neoplasms; Uterus | 1991 |
[Androgens and other hormones in buserelin therapy].
Topics: Administration, Intranasal; Adolescent; Adult; Androgens; Buserelin; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Luteinizing Hormone; Pelvic Neoplasms; Progesterone; Prolactin; Sex Hormone-Binding Globulin | 1991 |
Tissue factors influencing growth and maintenance of endometriosis.
Topics: Adult; Buserelin; Danazol; Dinoprostone; Endometriosis; Endometrium; ErbB Receptors; Female; Follicle Stimulating Hormone; Humans; Immune Sera; Immunohistochemistry; Luteinizing Hormone; Progesterone; Receptors, Estrogen; Receptors, Progesterone | 1991 |
[Value of the tumor markers CA 125, Ca 19-9, CA 15-3 and CEA in endometriosis].
Topics: Adult; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Buserelin; Carcinoembryonic Antigen; Endometriosis; Female; Follow-Up Studies; Genital Neoplasms, Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Reoperation | 1991 |
Long-term suppression of ovarian function by a luteinizing-hormone releasing hormone agonist implant in patients with endometriosis.
Topics: Administration, Intranasal; Adult; Buserelin; Dose-Response Relationship, Drug; Drug Implants; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Injections, Subcutaneous; Menstruation; Ovarian Follicle; Ovary; Ovulation; Radioimmunoassay | 1990 |
A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310 Study Group.
Topics: Adult; Buserelin; Climacteric; Clinical Protocols; Danazol; Endometriosis; Estradiol; Female; Fertility; Humans; Menstruation; Pregnadienes; Safety | 1990 |
The effects of combining norethindrone with a gonadotropin-releasing hormone agonist in the treatment of symptomatic endometriosis.
Topics: Adult; Buserelin; Drug Therapy, Combination; Endometriosis; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Norethindrone; Self Administration | 1990 |
[Residual endometriosis following LHRH analog therapy].
Topics: Adult; Buserelin; Endometriosis; Estradiol; Female; Follow-Up Studies; Humans; Ovarian Neoplasms; Ovary; Peritoneal Neoplasms; Peritoneum; Uterine Neoplasms; Uterus | 1990 |
Comparison of different ovarian stimulation protocols for gamete intrafallopian transfer in patients with minimal and mild endometriosis.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Endometriosis; Estradiol; Female; Gamete Intrafallopian Transfer; Humans; Infertility, Female; Ovulation Induction; Prospective Studies; Uterine Neoplasms | 1990 |
Treatment of endometriosis with gonadotropin releasing hormone agonist (buserelin).
Topics: Adult; Buserelin; Endometriosis; Estradiol; Female; Gonadotropins, Pituitary; Humans; Progesterone; Uterine Neoplasms | 1990 |
The value of pre-treatment with gonadotrophin releasing hormone (GnRH) analogue in IVF-ET therapy of severe endometriosis.
Topics: Buserelin; Embryo Transfer; Endometriosis; Female; Fertilization in Vitro; Humans; Infertility, Female; Oocytes; Pregnancy | 1990 |
Endometriosis-associated infertility treated by long-term gonadotropin-releasing hormone agonist administration and assisted fertilization.
Topics: Adult; Buserelin; Endometriosis; Female; Fertilization in Vitro; Humans; Infertility, Female | 1990 |
[Treatment of endometriosis. Evaluation of preoperative therapy with danazol, gestrinone and buserelin (nasal spray and implant)].
Topics: Administration, Intranasal; Adult; Buserelin; Danazol; Endometriosis; Female; Gestrinone; Humans; Preoperative Care; Prospective Studies; Uterine Neoplasms | 1990 |
[Cardiovascular hemodynamics by administration of buserelin acetate].
Topics: Administration, Intranasal; Adult; Buserelin; Endometriosis; Female; Hemodynamics; Humans; Pulse | 1990 |
Gonadotropin-releasing hormone analogs in the treatment of endometriomas.
Topics: Buserelin; Danazol; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Nafarelin | 1990 |
The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay.
Topics: Adult; Aged; Biological Assay; Buserelin; Endometriosis; Female; Fluorescent Antibody Technique; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Menopause; Middle Aged; Nafarelin; Orchiectomy; Ovarian Neoplasms; Ovariectomy; Prostatic Neoplasms; Radioimmunoassay; Uterine Neoplasms | 1990 |
[Ovarian suppression by the GnRH analog buserelin in the treatment of endometriosis. Clinical, biochemical and pelviscopic studies].
Topics: Administration, Intranasal; Adult; Buserelin; Climacteric; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Genital Neoplasms, Female; Humans; Infertility, Female; Laparoscopy; Luteinizing Hormone; Neoplasm Staging; Ovarian Function Tests; Ovulation; Pregnancy; Progesterone | 1990 |
Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results.
Topics: Adult; Buserelin; Delayed-Action Preparations; Endocrine Glands; Endometriosis; Female; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Goserelin; Humans; Menstrual Cycle; Prolactin | 1990 |
Gonadotrophin releasing hormone agonist (buserelin) in the treatment of endometriosis: changes in the extent of the disease and in CA 125 serum levels after 6-month therapy.
Topics: Adult; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Buserelin; Endometriosis; Female; Humans; Laparoscopy; Prospective Studies; Time Factors; Uterine Neoplasms | 1990 |
Medical treatment of mild endometriosis in infertile women: analysis of a failure.
Topics: Buserelin; Danazol; Endometriosis; Female; Gestrinone; Gonadotropin-Releasing Hormone; Humans; Nafarelin | 1990 |
Plasma and peritoneal fluid levels of CA 125 in women with endometriosis.
Topics: Antigens, Tumor-Associated, Carbohydrate; Ascitic Fluid; Buserelin; Contraceptives, Oral; Danazol; Endometriosis; Epitopes; Female; Gestrinone; Humans | 1988 |
Serum concentration and urinary excretion of the luteinizing hormone-releasing hormone agonist buserelin in patients with endometriosis.
Topics: Administration, Intranasal; Adult; Biological Availability; Buserelin; Chromatography, High Pressure Liquid; Endometriosis; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Injections, Intravenous; Luteinizing Hormone; Radioimmunoassay | 1989 |
Cortical and trabecular bone mineral content in women with endometriosis: effect of gonadotropin-releasing hormone agonist and danazol.
Topics: Adult; Bone and Bones; Buserelin; Danazol; Endometriosis; Female; Humans; Minerals; Pregnadienes | 1989 |
[Successful treatment of endometriosis in women with continuous subcutaneous infusion of gonadotropin-releasing hormone agonist (GnRH-A)].
Topics: Adult; Buserelin; Drug Evaluation; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Infusions, Parenteral; Luteinizing Hormone; Ovary; Pituitary Gland, Anterior; Prolactin; Thyrotropin-Releasing Hormone | 1989 |
[Continuous subcutaneous infusion of GnRH agonist: effective dosage in the treatment of endometriosis and its influence on the ovarian response to human menopausal gonadotropin].
Topics: Adult; Buserelin; Drug Interactions; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Infusions, Parenteral; Luteinizing Hormone; Menotropins; Ovary; Ovulation | 1989 |
[Turner syndrome with peritoneal endometriosis and ascites--therapeutic effects of buserelin therapy].
Topics: Adult; Ascites; Buserelin; Combined Modality Therapy; Endometriosis; Female; Humans; Hysterectomy; Peritoneal Neoplasms; Turner Syndrome | 1989 |
Studies on GnRH agonist suppression of estrogen production in patients with endometriosis.
Topics: Administration, Intranasal; Adult; Buserelin; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Radioimmunoassay | 1989 |
[Hormonal changes in buserelin therapy].
Topics: Adult; Buserelin; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Genital Neoplasms, Female; Gonadal Steroid Hormones; Humans; Luteinizing Hormone; Middle Aged; Progesterone; Prolactin | 1989 |
Endometriosis of the lung.
Topics: Adult; Buserelin; Danazol; Endometriosis; Female; Humans; Lung; Lung Neoplasms; Radiography, Thoracic | 1989 |
[Long-term follow-up of 14 patients with endometriosis, who were treated with the LHRH analog buserelin].
Topics: Administration, Intranasal; Adult; Buserelin; Endometriosis; Fallopian Tube Neoplasms; Female; Follow-Up Studies; Humans; Infertility, Female; Uterine Neoplasms | 1989 |
Long-term use of the low dose LHRH analogue combined with monthly medroxy-progesterone administration.
Topics: Adult; Buserelin; Drug Therapy, Combination; Dysmenorrhea; Endometriosis; Female; Humans; Medroxyprogesterone; Menorrhagia | 1989 |
LH-RH agonist (buserelin): treatment of endometriosis. Clinical, laparoscopic, endocrine and metabolic evaluation.
Topics: Buserelin; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Uterine Neoplasms | 1989 |
Intranasal LHRH agonist combined periodically with a progestogen for contraception.
Topics: Administration, Intranasal; Buserelin; Contraceptive Agents, Female; Drug Evaluation; Endometriosis; Female; Humans; Medroxyprogesterone; Menstruation Disturbances | 1989 |
Endometriosis: treatment with gonadotropin-releasing hormone agonist Buserelin.
Topics: Adult; Buserelin; Dysmenorrhea; Endometriosis; Female; Follow-Up Studies; Hormones; Humans; Infertility, Female; Laparoscopy; Menstrual Cycle; Pelvic Neoplasms; Pregnancy | 1989 |
[Buserelin--a GnRh analog for the treatment of endometriosis].
Topics: Administration, Intranasal; Adult; Buserelin; Drug Evaluation; Endometriosis; Female; Humans; Laparoscopy; Laparotomy | 1989 |
[Studies on endocrine therapy of endometriosis].
Topics: Animals; Buserelin; Danazol; Drug Therapy, Combination; Endometriosis; Estradiol; Female; Gestrinone; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovary; Pregnadienes; Rats; Rats, Inbred Strains | 1989 |
[The effect of buserelin therapy in endometriosis].
Topics: Administration, Intranasal; Adult; Buserelin; Endometriosis; Female; Follow-Up Studies; Genital Neoplasms, Female; Humans; Laparoscopy; Middle Aged | 1989 |
Rationale in use of LHRH analogues in endometriosis.
Topics: Buserelin; Danazol; Endometriosis; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Nafarelin | 1989 |
Zoladex versus danazol in the treatment of pelvic endometriosis: effects on plasma lipid risk factors.
Topics: Buserelin; Cholesterol; Danazol; Endometriosis; Female; Goserelin; Humans; Lipoproteins; Pelvic Neoplasms; Pregnadienes; Risk Factors; Triglycerides | 1989 |
A comparison of the skeletal effects of goserelin and danazol in premenopausal women with endometriosis.
Topics: Adult; Bone Density; Buserelin; Danazol; Endometriosis; Female; Goserelin; Humans; Osteoporosis; Pregnadienes | 1989 |
Clinical appreciation of LHRH analogue formulations.
Topics: Buserelin; Delayed-Action Preparations; Endometriosis; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Nafarelin; Triptorelin Pamoate | 1989 |
A new treatment for endometriosis.
Topics: Administration, Cutaneous; Buserelin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Endometriosis; Estradiol; Female; Goserelin; Humans | 1989 |
Round table discussion of endometriosis and its treatment.
Topics: Biopsy; Buserelin; Danazol; Endometriosis; Female; Humans; Laparoscopy; Ovarian Neoplasms; Peritoneal Neoplasms | 1986 |
Monthly implant of luteinizing hormone-releasing hormone agonist: a practical therapeutic approach for sex-steroid dependent gynecologic diseases.
Topics: Buserelin; Delayed-Action Preparations; Endometriosis; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Uterine Neoplasms | 1987 |
GnRH agonists-antagonists--clinical applications.
Topics: Buserelin; Danazol; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Nafarelin; Osteolysis; Polycystic Ovary Syndrome; Uterine Neoplasms | 1988 |
[Inhibitory effect of prolactin secretion by luteinizing hormone releasing hormone agonist (buserelin)].
Topics: Administration, Intranasal; Adult; Buserelin; Depression, Chemical; Endometriosis; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Prolactin; Uterine Neoplasms | 1986 |
[Initial results in the treatment of endometriosis with the LH-RH analog buserelin].
Topics: Adult; Buserelin; Endometriosis; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Genital Neoplasms, Female; Humans; Luteinizing Hormone; Neoplasm Staging; Ovary; Progesterone | 1986 |
Reversible pituitary ovarian suppression induced by an LHRH agonist in the treatment of endometriosis--comparison of two dose regimens.
Topics: Buserelin; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Luteinizing Hormone; Menstruation; Uterine Neoplasms | 1986 |
Treatment with a luteinising hormone-releasing hormone analogue (Buserelin) in danazol-resistant endometriosis patients.
Topics: Adult; Buserelin; Danazol; Drug Resistance; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Lynestrenol; Menstrual Cycle; Pregnadienes | 1986 |
[Metabolic effects and general side effects in the treatment of endometriosis with an LHRH agonist].
Topics: Adult; Buserelin; Endometriosis; Energy Metabolism; Female; Genital Neoplasms, Female; Humans | 1987 |
LH-RH agonist treatment of endometriosis.
Topics: Buserelin; Endometriosis; Estradiol; Female; Fertility; Genital Neoplasms, Female; Humans; Ovulation | 1987 |
Effects of danazol, gonadotropin-releasing hormone agonist, and estrogen/progestogen combination on experimental endometriosis in the ovariectomized rat.
Topics: Animals; Buserelin; Danazol; Endometriosis; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Norgestrel; Ovariectomy; Pregnadienes; Progesterone; Rats; Rats, Inbred Strains; Receptors, Estradiol; Receptors, Estrogen; Receptors, Progesterone | 1988 |
Prevention of follicular maturation in endometriosis by subcutaneous infusion of luteinizing hormone-releasing hormone agonist started in the luteal phase.
Topics: Adult; Buserelin; Endometriosis; Female; Follicle Stimulating Hormone; Humans; Luteal Phase; Luteinizing Hormone; Ovarian Follicle | 1988 |
Histologic study of ovarian endometriosis after hormonal therapy.
Topics: Adult; Buserelin; Endometriosis; Female; Gestrinone; Humans; Lynestrenol | 1988 |
Bone mineral density in women with endometriosis before and during ovarian suppression with gonadotropin-releasing hormone agonists or danazol.
Topics: Adult; Amenorrhea; Bone and Bones; Buserelin; Danazol; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Minerals; Ovary; Pregnadienes; Progesterone | 1988 |
A comparison of the effects of Buserelin versus danazol on plasma lipoproteins during treatment of pelvic endometriosis.
Topics: Adult; Buserelin; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Danazol; Endometriosis; Female; Humans; Lipoproteins; Pregnadienes | 1988 |
[Clinical experiences in the treatment of endometriosis with the LH-RH analog buserelin with special reference to the post-therapy course].
Topics: Adult; Buserelin; Dysmenorrhea; Endometriosis; Female; Follow-Up Studies; Genital Neoplasms, Female; Genitalia, Female; Humans; Luteinizing Hormone; Progesterone | 1988 |
Effect of LHRH agonist (buserelin) on pulsatile secretion of LHRH and LH.
Topics: Adult; Buserelin; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Ovulation; Pelvic Neoplasms; Secretory Rate | 1988 |
[Medical treatment of endometriosis].
Topics: Buserelin; Danazol; Endometriosis; Female; Gestrinone; Humans; Norpregnatrienes; Pregnadienes; Uterine Neoplasms | 1985 |